Carolyn Lefkowits
Papers
1
Total Citations
133
H-Index
1
About
Dr. Carolyn Lefkowits is a leading gynecologic oncologist whose research centers on optimizing perioperative care and thromboprophylaxis in women with gynecologic malignancies. Her most impactful work, a 2020 study with 133 citations, directly addressed a critical clinical challenge: the low adherence and high cost of the standard 28-day enoxaparin regimen for preventing venous thromboembolism after gynecologic cancer surgery. By demonstrating the safety and efficacy of apixaban as an alternative, Dr. Lefkowits provided compelling evidence for a more patient-friendly, oral anticoagulation strategy. This landmark contribution has the potential to reshape postoperative guidelines, improving both patient outcomes and quality of life. Her research is distinguished by its focus on translating real-world barriers—such as medication cost and compliance—into actionable, evidence-based solutions. Through her work, Dr. Lefkowits has established herself as a key voice in the effort to refine and personalize supportive care for women undergoing surgery for gynecologic malignant neoplasms.
Research Focus
Key Achievements
Top Papers
- 1